Regeneron Pharmaceuticals Inc

مادة اعلانية

Latest Update: 21 Feb 2026 00:59 Abu Dhabi Time.

Market Status: Closed

REGN

Regeneron Pharmaceuticals Inc

779.59

USD

-1.850

-0.24%

Open

775.03

Prev Close

779.67

PX_VOLUME

MARKET CAP (M)

DAY RANGE

770.00 - 781.46

52 WEEKS

476.49 - 821.11

Stock Statistics

Yearly Change

12.02%

Listed Shares (Million)

137.60

Earnings Multiple

18.80

Average 30-day trading volume

1,062,332.48

Price-to-book ratio

2.64

Earnings Per Share

43.49

Previous Dividend Distribution

3.52

Dividend Yield

0.45%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		3,884.30	3,754.30	3,675.60	3,028.70	3,789.20	3,720.70	3,547.10	3,145.00	3,434.30	3,362.70
Gross Profit		3,472.60	3,232.70	3,145.40	2,564.40	3,350.10	3,229.60	3,066.90	2,711.20	3,019.60	2,926.30
Operating Income		1,071.50	1,109.90	1,089.50	604.00	1,145.80	1,243.70	1,108.10	773.80	1,105.20	1,211.00
Net Income		844.60	1,504.50	1,391.60	808.70	917.70	1,340.60	1,432.30	722.00	1,159.60	1,007.80
Profit Margin		21.74	40.07	37.86	26.70	24.22	36.03	40.38	22.96	33.77	29.97

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		14,342.90	14,202.00	13,117.20	12,172.90	16,071.70	8,497.10
Gross Profit		12,415.10	12,357.80	11,403.70	10,871.20	13,865.90	7,377.20
Operating Income		3,874.90	4,271.40	4,335.50	5,252.70	9,222.50	3,566.60
Net Income		4,549.40	4,412.60	3,953.60	4,338.40	8,075.30	3,513.20
Profit Margin		31.72	31.07	30.14	35.64	50.25	41.35

Balance Sheet

	Period Ending:	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		40,558.70	40,169.40	38,219.20	37,545.20	37,759.40	37,441.90	36,086.80	34,369.60	33,080.20	32,163.30
Total Liabilities		9,301.80	9,211.60	8,280.30	8,157.60	8,405.80	8,116.00	7,881.00	7,378.50	7,107.10	7,258.90
Total Equity		31,256.90	30,957.80	29,938.90	29,387.60	29,353.60	29,325.90	28,205.80	26,991.10	25,973.10	24,904.40

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		40,558.70	37,759.40	33,080.20	29,214.50	25,434.80	17,163.30
Total Liabilities		9,301.80	8,405.80	7,107.10	6,550.50	6,666.00	6,138.00
Total Equity		31,256.90	29,353.60	25,973.10	22,664.00	18,768.80	11,025.30

Cash Flows Statements

	Period Ending:	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Cash From Operating Activities		1,170.70	1,618.70	1,144.40	1,045.10	1,262.80	1,291.20	354.00	1,512.50	1,089.70	1,114.30
Cash From Investing Activities		220.30	-402.90	-1,094.00	647.50	350.60	-574.40	-557.20	-1,687.10	-66.20	-496.30
Cash From Financing Activities		-780.10	-717.90	-1,128.20	-1,089.20	-1,135.50	-634.00	-478.10	47.10	-446.10	-407.30
Net Change in Cash		610.60	497.50	-1,077.40	604.00	477.20	83.60	-681.60	-128.00	577.60	210.50

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash From Operating Activities		4,978.90	4,420.50	4,594.00	5,014.90	7,081.30	2,618.10
Cash From Investing Activities		-629.10	-2,468.10	-3,185.10	-3,784.60	-5,384.70	-70.60
Cash From Financing Activities		-3,715.40	-2,200.50	-1,790.10	-1,009.00	-1,005.80	-1,970.50
Net Change in Cash		634.70	-248.80	-381.60	221.30	690.80	577.00

* In Million of United States Dollar

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

REGN

Regeneron Pharmaceuticals Inc

ريجينيرون فارماسوتيكالز